PATH | VRL
Menu

Formulation of a Killed Whole Cell Pneumococcus Vaccine—Effect of Aluminum Adjuvants on the Antibody and IL-17 Response

This article, published in the Journal of Immune Based Therapies and Vaccines, describes preclinical research which demonstrates that a vaccine composed of killed whole cell, nonencapsulated pneumococci and formulated with aluminum hydroxide induces a strong antibody and IL-17 response.

Author: HogenEsch H, Dunham A, Hansen B, Anderson K, Maisonneuve JF, Hem SL

Published: 2011

» Visit web page (English)

(Located at www.jibtherapies.com)

Citation: HogenEsch H, Dunham A, Hansen B, Anderson K, Maisonneuve JF, Hem SL. Formulation of a Killed Whole Cell Pneumococcus Vaccine—Effect of Aluminum Adjuvants on the Antibody and IL-17 Response. Journal of Immune Based Therapies and Vaccines. 2011;9(5).

Resource types: Peer-reviewed journal

Diseases/vaccines: Pneumococcus

Topics: Disease/vaccine specific information

Regions: Global